2025 Plenary Keynote Sessions
Tuesday, March 11
8:00 am Chairperson's Remarks
Edward Abrahams, PhD, President, Personalized Medicine Coalition
8:05 am Plenary Keynote Introduction (Sponsorship Available)
8:15 am Plenary Keynote Fireside Chat: A New Era in Healthcare: Making Precision Medicine a Reality
Gabriele Allegri, MBA, Vice President, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine
Interviewed By:
Edward Abrahams, PhD, President, Personalized Medicine Coalition
8:45 am Panel Discussion: The Pharmaceutical Industry and Precision Medicine
Moderator:
Edward Abrahams, PhD, President, Personalized Medicine Coalition
Personalized or precision medicine depends upon linking prescribed therapies to diagnostics so that the right patient gets the right drug at the right time. Yet bringing the therapeutics and diagnostics together does not come easily as the pharmaceutical and diagnostic industries do not share the same business models or cultures. This panel discussion will explore what pharmaceutical executives look for when partnering with colleagues in diagnostics to develop targeted therapies.
Panelists:
Steffan Ho, MD, PhD, Vice President, Head of Translational Oncology, Pfizer
Andrea L. Stevens, PhD, Senior Director, Precision Medicine Access, J&J Innovative Medicine
Lourdes Barrera, PhD, Executive Director, Global Medical Affairs Oncology—Precision Medicine, Merck
Omar Perez, PhD, Head of Medical Diagnostics, US Medical Affairs Oncology, AstraZeneca
3:40 pm Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
3:45 pm Plenary Keynote Fireside Chat
Peter Foley, Founder & CEO, LetsGetChecked
In this fireside chat, Peter Foley, CEO and founder of LetsGetChecked, will explore the mission and vision that have driven the company’s rapid growth and innovation in home health management. He will share insights into the journey of scaling from a direct-to-consumer model to a robust business-to-business platform, addressing the challenges of integrating health insights and advanced clinical diagnostics with exceptional customer care. From immunoassays and clinical chemistry to genomics, Peter will discuss how LetsGetChecked leverages cutting-edge technologies to empower precision medicine at scale, delivering tailored healthcare solutions that meet the unique needs of millions of individual patients. This conversation will highlight the transformative role of precision medicine, patient-focused care models, and innovative digital platforms in shaping a more connected and responsive healthcare ecosystem that delivers measurable value for all stakeholders.
Interviewed By:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
4:15 pm Panel Discussion: Driving Innovation in Precision Medicine: CEO Perspective
Moderator:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
Panelists:
Lisa Alderson, CEO, Adela, Inc.
Alex Aravanis, MD, PhD, CEO, Moonwalk Biosciences
Susan Tousi, CEO, DELFI Diagnostics
Wednesday, March 12
8:00 am Chairperson's Remarks
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
8:05 am Plenary Keynote Introduction (Sponsorship Available)
8:15 am Panel Discussion: Investing in Precision Medicine Innovation: What Defines Success?
Moderator:
Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter
Panelists:
Ajit Singh, PhD, Partner, Artiman Ventures
Jenny Rooke, PhD, Managing Director, Genoa Ventures
Michael Hadjisavas, PhD, Executive Advisor, GreyBird Ventures LLC
4:15 pm Panel Discussion: Tech Trends in Precision Medicine
Moderator:
Jonathan D. Grinstein, PhD, North America Editor, Inside Precision Medicine
Leading technology companies will discuss future trends, needs, and solutions needed to drive precision medicine forward, including innovation in genomics and diagnostics, artificial intelligence and digital tech, multiomic analysis, biomarkers, and clinical trials.
Panelists
Aaron Sin, Senior Director Research & Technology Development, Diagnostics & Regulated Materials, MilliporeSigma
T.J. Chen, PhD, Head of Genomics Products, Healthcare, and Life Sciences, NVIDIA
Damon Hostin, Lead, Market Access, Health Systems, Illumina, Inc.
Shawn Fahl, PhD, Vice President, Lab Operations, Cell Services & R&D, Biospecimens, Discovery Life Sciences